arrow
BackJournal Details
L

Lancet Diabetes & Endocrinology

IF41.8
Papers23
Citations
Journal Papers 22
Publication Date
The glucagon renaissance in obesity therapeutics
delete2026-08-21
delete0
PREAI
deleteMarcel H A Muskiet; Beatrice Bottini; Sander Kooijman; Patrick C N Rensen
deleteShare
deleteSave
Efficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trial
delete2026-08-21
delete0
PREAI
deleteStanley H Hsia; Harold E Bays; Liana K Billings; Ann Marie K Weideman; Kieren J Mather; Tamer Coskun; Axel Haupt; Melissa K Thomas; Lai San Tham; Boris Calderon; Wei Ni; Olimpia Ferreira Galvao De Araujo
deleteShare
deleteSave
Time for personalised incretin titration
delete2026-08-19
delete0
PREAI
deleteRoman Vangoitsenhoven; Bart Van der Schueren; Chantal Mathieu; Christophe De Block; Luc Van Gaal; Eveline Dirinck
deleteShare
deleteSave
Type 2 diabetes management: weekly combination therapy comes of age?
delete2026-08-13
delete0
PREAI
deleteSrikanth Bellary; Muhammad Ali Karamat; Anthony H Barnett
deleteShare
deleteSave
Once-weekly IcoSema versus once-daily insulin glargine U100 in type 2 diabetes management (COMBINE 4): an open-label, multicentre, treat-to-target, randomised, phase 3b trial
delete2026-08-13
delete0
PREAI
deleteLinong Ji; Malik Benamar; Viswanathan Mohan; Laura Pletsch-Borba; Francesca Porcellati; Ni Wang; Hirotaka Watada; Rosangela R Rea
deleteShare
deleteSave
Do weight loss and weight cycling present a clinically meaningful risk in older patients?
delete2026-08-11
delete0
PREAI
deleteHenning T Langer; Ursula Müller-Werdan; Stefan D Anker; Kristina Norman
deleteShare
deleteSave
Efficacy and safety of once-weekly semaglutide 2·4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial
delete2026-08-10
delete0
PREAI
deleteLixin Guo; Xiaolei Bao; Kuo-Chin Huang; Kristoffer Jensen Kolnes; Christian Laugesen; Yibing Lu; Bifen Luo; Guoyue Yuan; Robert F Kushner
deleteShare
deleteSave
Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis
delete2026-08-07
delete0
PREAI
deleteJohannes F E Mann; Sunil V Badve; Florian M M Baeres; Nicolas Belmar; Kirstine Brown-Frandsen; John B Buse; Helen M Colhoun; John E Deanfield; Mads D M Engelmann; G Kees Hovingh; Thomas Idorn; A Michael Lincoff; Ildiko Lingvay; Kenneth W Mahaffey; Darren K McGuire; Richard E Pratley; Søren Rasmussen; Peter Rossing; Naveed Sattar; Katherine R Tuttle
deleteShare
deleteSave
Type 1 diabetes in older populations
delete2026-07-30
delete0
PREAI
deleteAnna R Kahkoska; Peter K Yang; Joshua J Neumiller; Anastasia-Stefania Alexopoulos; Nancy A Allen; Naomi S Chaytor; Michael Fang; Jonathan A Golding; Sanjay Kalra; David S Martins; Camille M Mba; Jean Claude Mbanya; Alan J Sinclair; Heather L Stuckey; Medha Munshi
deleteShare
deleteSave
Energy drink ban: putting children's health first
delete2026-07-29
delete0
PREAI
deletenull The Lancet Diabetes & Endocrinology
deleteShare
deleteSave
Soaring GLP-1 receptor agonist use
delete2026-07-29
delete0
PREAI
deletenull The Lancet Diabetes & Endocrinology
deleteShare
deleteSave
Nutritional, functional, and psychological considerations for incretin-based therapies in adults—an EASO, EFAD, and ECPO Consensus Statement
delete2026-07-08
delete0
PREAI
deleteLaurence J Dobbie; Liisa Tolvanen; Daniela Alves; Jennifer L Baker; Natalie S Bez; Susie Birney; Leonie H Bogl; Adrian Brown; Monica Bullo; Ken Clare; Emma L Duncan; Ellen Govers; Vicki Mooney; Hilda Mulrooney; Daniela Ojeda Mercado; Grace O’Malley; Jean-Michel Oppert; Toby Pillinger; Wineke Remijnse; Emma Shuttlewood
deleteShare
deleteSave
Treatment duration for romosozumab
delete2026-06-16
delete0
PREAI
deleteMichael R McClung; David Dempster; Felicia Cosman
deleteShare
deleteSave
Is weight cycling clinically harmful?
delete2026-05-14
delete0
PREAI
deleteFaidon Magkos; Norbert Stefan
deleteShare
deleteSave